The recently released 2023 Healthcare and Life Sciences Investment Outlook from KPMG finds turbulence, and opportunity, in this post-pandemic marketplace.
The extensive global research and annual survey of corporate and private equity deal makers analyzes how eight industry subsectors fared during a year characterized by macroeconomic and geopolitical upheaval, and how deal activity and market drivers could shape the 2023 investment landscape.
After years propelled by rapid innovation and strong…
